Common clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline <i>CHEK2</i> variant
Alexandre Bazinet(The University of Texas MD Anderson Cancer Center), François Mercier(McGill University)
Cited by 8
Related Papers
EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax
|Journal of Experimental & Clinical Cancer Research|2022|35
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)
|Blood|2024|3
<i>MECOM</i> fusion partner and bone marrow blast percentage influence outcomes of patients with <i>MECOM</i> rearranged acute myeloid leukaemia
|British Journal of Haematology|2025|3